4.5 Review

Pathogenesis and Treatment of Usher Syndrome Type IIA

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Genetics & Heredity

Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2

M. Stemerdink et al.

Summary: Usher syndrome is a rare genetic disorder characterized by sensory neural hearing loss and progressive vision loss. Research indicates that sleep deprivation, olfactory dysfunction, and other symptoms are also part of the disease. Genetic and clinical research, as well as therapeutic approaches for Usher syndrome, are currently being developed to potentially provide treatment for patients.

HUMAN GENETICS (2022)

Article Cell & Tissue Engineering

Establishment of iPS cell line (KLRMMEi002-A) by reprogramming peripheral blood mononuclear cells from a patient with USH2A-associated Usher syndrome

Liying Liang et al.

Summary: USH type 2 (USH2) is an autosomal recessive disorder characterized by inherited retinopathies and sensorineural hearing loss. Mutations in the USH2A gene account for a large percentage of USH2 cases. A patient-specific induced pluripotent stem (iPS) cell line with a specific USH2A gene mutation was successfully created, which can be used as a model for studying the pathogenic mechanisms of USH2A-associated disorders.

STEM CELL RESEARCH (2022)

Article Cell & Tissue Engineering

Generation of a human iPSC line, INMi005-A, from a patient with non-syndromic USH2A-associated retinitis pigmentosa

Carla Sanjurjo-Soriano et al.

Summary: We report the generation of a human iPSC line from a patient with autosomal recessive retinitis pigmentosa using the non-integrative Sendai virus method. The generated iPSC line is pluripotent and genetically stable, and will serve as a valuable tool for studying the pathophysiology associated with the disease.

STEM CELL RESEARCH (2022)

Article Audiology & Speech-Language Pathology

Usher Syndrome

Alessandro Castiglione et al.

Summary: Usher syndrome is a common genetic condition that causes combined loss of hearing and vision. It can be divided into three main clinical types, each caused by mutations in different genes. This review provides an overview of the causative genes, diagnosis, prognosis, epidemiology, rehabilitation, research, and new treatments for Usher syndrome.

AUDIOLOGY RESEARCH (2022)

Article Genetics & Heredity

Vestibular phenotype-genotype correlation in a cohort of 90 patients with Usher syndrome

Talah T. Wafa et al.

Summary: Usher syndrome has been traditionally categorized into three classical types based on patient phenotype, but the relationship between vestibular phenotype and Usher gene mutations is not definitive. Research shows that patients with different Usher syndrome types may exhibit varying vestibular dysfunctions, contrary to classical assumptions. Therefore, vestibular phenotyping data may not reliably differentiate between Usher syndrome types.

CLINICAL GENETICS (2021)

Article Cell & Tissue Engineering

Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene

Khine Zaw et al.

Summary: In this study, three induced pluripotent stem cell lines were successfully generated from dermal fibroblasts of a patient carrying biallelic mutations in the USH2A gene. These cell lines expressed pluripotency markers, had unaltered karyotypes, trilineage differentiation potential, and tested negative for reprogramming episomes and mycoplasma.

STEM CELL RESEARCH (2021)

Article Biotechnology & Applied Microbiology

Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations

Kalyan Dulla et al.

Summary: Mutations in the USH2A gene are common causes of retinitis pigmentosa, with skipping of exon 13 showing promise as a treatment modality. Research has demonstrated that QR-421a-induced exon skipping has the potential to be a highly effective treatment option for RP caused by mutations in USH2A exon 13.

MOLECULAR THERAPY (2021)

Article Cell & Tissue Engineering

Generation of two human induced pluripotent stem cell lines from patients with biallelic USH2A variants

Tian Zhu et al.

Summary: This study successfully established two human induced pluripotent stem cell lines from a RP patient with compound heterogeneous USH2A variants and a USH2 patient with homozygous USH2A variant. These iPSC lines retained the disease-associated variants and exhibited normal karyotype, pluripotency, and differentiation capacity.

STEM CELL RESEARCH (2021)

Article Genetics & Heredity

Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells

Xuezhong Liu et al.

Summary: Usher syndrome is the leading cause of inherited combined hearing and vision loss, affecting approximately 15,000 people in the United States. Through gene correction in patient iPSCs, this study establishes a foundation for future gene therapy research.
Article Medicine, Research & Experimental

Genome Editing in Patient iPSCs Corrects the Most Prevalent USH2A Mutations and Reveals Intriguing Mutant mRNA Expression Profiles

Carla Sanjurjo-Soriano et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Biochemistry & Molecular Biology

Clinical and Genetic Analysis of a European Cohort with Pericentral Retinitis Pigmentosa

Marianthi Karali et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

RNA-Targeting CRISPR-Cas Systems and Their Applications

Michal Burmistrz et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, Research & Experimental

Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trial

Peter A. Campochiaro et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

News Item Multidisciplinary Sciences

CRISPR TREATMENT INSERTED DIRECTLY INTO BODY FOR THE FIRST TIME

Heidi Ledford

NATURE (2020)

Review Biotechnology & Applied Microbiology

Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors

Andrew V. Anzalone et al.

NATURE BIOTECHNOLOGY (2020)

Article Medicine, Research & Experimental

Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate

Bence Gyorgy et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)

Review Audiology & Speech-Language Pathology

Cochlear histopathology in human genetic hearing loss: State of the science and future prospects

Krishna Bommakanti et al.

HEARING RESEARCH (2019)

Article Medicine, General & Internal

Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease

J. Kim et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Clinical Neurology

Genetics of Usher Syndrome: New Insights From a Meta-analysis

Guillaume Jouret et al.

OTOLOGY & NEUROTOLOGY (2019)

Article Ophthalmology

Usherin defects lead to early-onset retinal dysfunction in zebrafish

Margo Dona et al.

EXPERIMENTAL EYE RESEARCH (2018)

Article Biotechnology & Applied Microbiology

Triple Vectors Expand AAV Transfer Capacity in the Retina

Andrea Maddalena et al.

MOLECULAR THERAPY (2018)

Correction Biochemistry & Molecular Biology

UniProt: the universal protein knowledgebase (vol 45, pg D158, 2017)

Alexandre Renaux

NUCLEIC ACIDS RESEARCH (2018)

Article Biotechnology & Applied Microbiology

Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c

Bifeng Pan et al.

NATURE BIOTECHNOLOGY (2017)

Article Biotechnology & Applied Microbiology

Generation of inner ear organoids containing functional hair cells from human pluripotent stem cells

Karl R. Koehler et al.

NATURE BIOTECHNOLOGY (2017)

Article Otorhinolaryngology

Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation

Giuseppe Magliulo et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)

Article Multidisciplinary Sciences

Local gene therapy durably restores vestibular function in a mouse model of Usher syndrome type 1G

Alice Emptoz et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Neurosciences

Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting

Livia S. Carvalho et al.

FRONTIERS IN NEUROSCIENCE (2017)

Article Medicine, Research & Experimental

USH2A Gene Editing Using the CRISPR System

Carla Fuster-Garcia et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2017)

Article Medicine, Research & Experimental

Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation

Radulfus WN Slijkerman et al.

Molecular Therapy-Nucleic Acids (2016)

Article Biochemistry & Molecular Biology

Is There Excess Oxidative Stress and Damage in Eyes of Patients with Retinitis Pigmentosa?

Peter A. Campochiaro et al.

ANTIOXIDANTS & REDOX SIGNALING (2015)

Article Biochemical Research Methods

Identification of extracellularly phosphorylated membrane proteins

Sandra Burghoff et al.

PROTEOMICS (2015)

Article Ophthalmology

Clinical Aspects of Usher Syndrome and the USH2A Gene in a Cohort of 433 Patients

Fiona Blanco-Kelly et al.

JAMA OPHTHALMOLOGY (2015)

Review Medicine, Research & Experimental

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Xiao-Hui Zhang et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2015)

Article Biotechnology & Applied Microbiology

Dual Adeno-Associated Virus Vectors Result in Efficient In Vitro and In Vivo Expression of an Oversized Gene, MYO7A

Frank M. Dyka et al.

HUMAN GENE THERAPY METHODS (2014)

Article Medicine, Research & Experimental

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene

Kane L. Greer et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2014)

Article Biochemistry & Molecular Biology

CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes

Luke A. Gilbert et al.

Article Biochemistry & Molecular Biology

Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus

V. S. Lopes et al.

GENE THERAPY (2013)

Article Audiology & Speech-Language Pathology

Expressivity of hearing loss in cases with Usher syndrome type IIA

Andre M. Sadeghi et al.

INTERNATIONAL JOURNAL OF AUDIOLOGY (2013)

Article Biochemical Research Methods

CRISPR interference (CRISPRi) for sequence-specific control of gene expression

Matthew H. Larson et al.

NATURE PROTOCOLS (2013)

Article Multidisciplinary Sciences

Myosin7a Deficiency Results in Reduced Retinal Activity Which Is Improved by Gene Therapy

Pasqualina Colella et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Altered Antioxidant-Oxidant Status in the Aqueous Humor and Peripheral Blood of Patients with Retinitis Pigmentosa

Cristina Martinez-Fernandez de la Camara et al.

PLOS ONE (2013)

Article Biochemistry & Molecular Biology

Current understanding of usher syndrome type II

Jun Yang et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2012)

Article Genetics & Heredity

Nasal Epithelial Cells are a Reliable Source to Study Splicing Variants in Usher Syndrome

Christel Vache et al.

HUMAN MUTATION (2010)

Article Medicine, Research & Experimental

PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome

Inga Ebermann et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Review Clinical Neurology

Update on Usher syndrome

Zubin Saihan et al.

CURRENT OPINION IN NEUROLOGY (2009)

Article Biochemistry & Molecular Biology

Identification of two new mutations in the GPR98 and the PDE6B genes segregating in a Tunisian family

Mounira Hmani-Aifa et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2009)

Article Genetics & Heredity

Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II

Bo Dreyer et al.

HUMAN MUTATION (2008)

Article Cell Biology

Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa

Keiichi Komeima et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2007)

Article Biotechnology & Applied Microbiology

Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript

Steve D. Wilton et al.

MOLECULAR THERAPY (2007)

Article Multidisciplinary Sciences

Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells

Xiaoqing Liu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Medicine, General & Internal

Retinitis pigmentosa

Dyonne T. Hartong et al.

LANCET (2006)

Article Multidisciplinary Sciences

Antioxidants reduce cone cell death in a model of retinitis pigmentosa

Keiichi Komeima et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Biochemistry & Molecular Biology

Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2

J Reiners et al.

HUMAN MOLECULAR GENETICS (2005)

Article Biochemistry & Molecular Biology

Evidence for functional importance of usherin/fibronectin interactions in retinal basement membranes

G Battacharya et al.

BIOCHEMISTRY (2005)

Article Cell Biology

Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa

JK Shen et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2005)

Article Genetics & Heredity

A common ancestral origin of the frequent and widespread 2299delG USH2A mutation

B Dreyer et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2001)

Review Neurosciences

PDZ domains and the organization of supramolecular complexes

M Sheng et al.

ANNUAL REVIEW OF NEUROSCIENCE (2001)

Article Genetics & Heredity

Missense mutation in the USH2A gene:: Association with recessive retinitis pigmentosa without hearing loss

C Rivolta et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2000)